Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Usary

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Protocols in Pharmacology|March 21, 2016
Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer SubtypesJerry Usary, David Brian Darr, Adam D Pfefferle, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 17, 2012
Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor modelsSarah M Dunlap, Lucia J Chiao, Leticia Nogueira, et al.
Genes & Cancer|March 15, 2013
Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer SubtypesBrittni A Smith, Dawne N Shelton, Collin Kieffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Estrogen-regulated genes predict survival in hormone receptor-positive breast cancersDaniel S Oh, Melissa A Troester, Jerry Usary, et al.
Cancer Cell|May 5, 2009
CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesisXin-Hai Pei, Feng Bai, Matthew D Smith, et al.
NPJ Breast Cancer|July 28, 2017
Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancerCiara H O'Flanagan, Emily L Rossi, Shannon B McDonell, et al.
Plos One|June 16, 2011
The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimusSharareh Siamakpour-Reihani, Joseph Caster, Desh Bandhu Nepal, et al.
Breast Cancer Research and Treatment|November 29, 2018
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancerDaniel P Hollern, Cristina M Contreras, Stephanie Dance-Barnes, et al.
BMC Genomics|April 29, 2004
Universal Reference RNA as a standard for microarray experimentsNatalia Novoradovskaya, Michael L Whitfield, Lee S Basehore, et al.
Oncotarget|December 20, 2017
Differential response to exercise in claudin-low breast cancerOliver K Glass, Michelle Bowie, Julie Fuller, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Protocols in Pharmacology|March 21, 2016
Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer SubtypesJerry Usary, David Brian Darr, Adam D Pfefferle, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 17, 2012
Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor modelsSarah M Dunlap, Lucia J Chiao, Leticia Nogueira, et al.
Genes & Cancer|March 15, 2013
Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer SubtypesBrittni A Smith, Dawne N Shelton, Collin Kieffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Estrogen-regulated genes predict survival in hormone receptor-positive breast cancersDaniel S Oh, Melissa A Troester, Jerry Usary, et al.
Cancer Cell|May 5, 2009
CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesisXin-Hai Pei, Feng Bai, Matthew D Smith, et al.
NPJ Breast Cancer|July 28, 2017
Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancerCiara H O'Flanagan, Emily L Rossi, Shannon B McDonell, et al.
Plos One|June 16, 2011
The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimusSharareh Siamakpour-Reihani, Joseph Caster, Desh Bandhu Nepal, et al.
Breast Cancer Research and Treatment|November 29, 2018
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancerDaniel P Hollern, Cristina M Contreras, Stephanie Dance-Barnes, et al.
BMC Genomics|April 29, 2004
Universal Reference RNA as a standard for microarray experimentsNatalia Novoradovskaya, Michael L Whitfield, Lee S Basehore, et al.
Oncotarget|December 20, 2017
Differential response to exercise in claudin-low breast cancerOliver K Glass, Michelle Bowie, Julie Fuller, et al.
Pageof 2